Articles tagged "Kidney transplantation"

2016 American Transplant Congress
Clinical Outcome on Kidney Retransplantation in Comparison with First Kidney Transplantation in Korea – Nationwide Cohort Study.
J. Kim,^1,2 T. Ban,^1,2 B. Jung,^1,2 B. Choi,^1,2 C. Park,^1,2 C. Yang,^1,2 Y.-S. Kim.^1,2
¹Transplantation Research Center, Seoul St. Mary's Hospital, Seoul, Republic of Korea; ²Internal Medicine, Seoul St. Mary's Hospital, Seoul, Republic of Korea.
Due to the limitation of the survival of kidney allograft, increasing number of patients need to take re-transplantation (re-KT) after the first allograft failure. In…
2016 American Transplant Congress
Predictors of Outcomes After Kidney Transplantation in the Setting of Chronic Opiate Use.
R. Evans,¹ N. Neville,² A. Fugit,³ R. Gedaly,¹ T. Clifford.¹
¹University of Kentucky Healthcare, Lexington, KY; ²University of Kentucky College of Pharmacy, Lexington, KY; ³Vidant Medical Center, Greenville, NC.
Purpose: To determine the impact and correlation of pre-transplant chronic opiate use with post-transplant chronic opiate use, resource utilization, and patient survival in addition to…
2016 American Transplant Congress
Post-Transplant Vaccine Initiative Collaboration (VIC) in a Multidisciplinary, Transplant Ambulatory Setting.
G. Malat,⁴ S. DiLollo,¹ D. Lee,² A. Sharma,³ T. Bias,² M. Harhay,³ K. Ranganna,³ A. Doyle.³
¹Colonia Natural Pharmacy, Colonia; ²Medicine/Surgery, Drexel University, Philadelphia.
Introduction We describe the implementation of a vaccine initiative in an ambulatory transplant setting.Methods In 2014, Hahnemann University Hospital (HUH) and Colonia Natural Pharmacy transplant…
2016 American Transplant Congress
High Tacrolimus Dose Requirements at Month 6 Are Associated with Inferior Graft Function in Renal Transplant Patients.
O. Rissling, S. Brakemeier, L. Lehner, F. Halleck, O. Staeck, D. Schmidt, K. Budde.
Department of Nephrology, Charité Universitaetsmedizin, Berlin, Germany.
Introduction: Tacrolimus (Tac), the mainstay of immunosuppression in renal transplant (tx) patients (pts) is known for drug induced nephrotoxicity, which may limit graft survival.Methods: In…
2016 American Transplant Congress
High KDPI Is a Predictor of Acute Rejection in Delayed Graft Function.
B. Muth,¹ J. Turk,¹ S. Parajuli,¹ D. Mandelbrot,¹ M. Mohamed,¹ R. Redfield,² D. Kaufman,² A. Djamali.^1,2
¹Department of Medicine, Division of Nephrology, University of Wisconsin School of Medicine and Public Health, Madison, WI; ²Department of Surgery, Division of Transplantation, University of Wisconsin School of Medicine and Public Health, Madison, WI.
The kidney donor profile index (KDPI) is a prognostic measure for graft function and survival. It is unclear whether it predicts acute rejection in patients…
2016 American Transplant Congress
Pre-Transplant Coronary Artery Disease: An Underestimated Risk Factor for Post-Transplant Mortality?
D. Khadzhynov, F. Halleck, L. Lehner, M. Duerr, A. Kleinsteuber, K. Budde, O. Staeck.
Nephrology, Charite Universitaetsmedizin, Berlin, Germany.
Background: Coronary artery disease is a frequent comorbidity among transplant candidates. Limited data exist on the long-term outcomes of kidney transplant recipients (KTR) with pre-existing…
2016 American Transplant Congress
Clinical Significance of C3d Binding Donor Specific Anti-HLA Antibodies (DSA) Detected by Single Antigen Beads (SAB) After Kidney Transplantation.
R. Pelletier,¹ I. Balazs,² P. Adams,³ P. Steller,³ N. DiPaola,⁴ L. Rankin,³ A. Diez,⁵ M. Henry.¹
¹Surgery/Transplant, The Ohio State University Wexner Medical Center, Columbus, OH; ²Discovery Research, Immucor, Inc, Stamford, CT; ³Tissue Typing Laboratory, The Ohio State University Wexner Medical Center, Columbus, OH; ⁴Methodist Hospital, Houston, TX; ⁵Nephrology, The Ohio State University Wexner Medical Center, Columbus, OH.
A new Luminex-based SAB method detects DSA compliment fixing via C3d-binding. This study compares the clinical outcomes in kidney recipients that developed de novo DSA…
2016 American Transplant Congress
Kidney Transplant Induction Therapies: Risks of Death, Allograft Failure, Sepsis, and Cancer.
N. Koyawala,¹ J. Silber,² P. Rosenbaum,¹ R. Bloom,¹ W. Wang,² A. Hill,² S. Nazarian,¹ D. Sawinski,¹ J. Trofe,¹ M. Lim,¹ J. Schold,³ P. Reese.¹
¹University of Pennsylvania, Philadelphia; ²The Children's Hospital of Philadelphia, Philadelphia; ³Cleveland Clinic, Cleveland.
Induction therapies are commonly used during kidney transplantation (~85% of transplants in 2012). Existing studies of induction therapy are limited by short follow-up and/or absence…
2016 American Transplant Congress
Impact of the New Kidney Allocation System on Highly Sensitized Patients: Single Center Report.
A. Mattiazzi,¹ W. Kupin,¹ D. Roth,¹ L. Chen,² G. Burke,² G. Ciancio,² P. Ruiz,² R. Vianna,² G. Guerra.¹
¹Department of Medicine, Division of Nephrology, Miami Transplant Institute, Miami, FL; ²Department of Surgery, Miami Transplant Institute, Miami, FL.
Background: Highly sensitized patients (HSP) with calculated Panel Reactive Antibody (cPRA) >80% are known to have extensive waiting time on UNOS list. The new kidney…
2016 American Transplant Congress
Clinical Outcomes of Kidney Allograft Recipients with Apolipoprotein L1 (APOL1) Risk Alleles from Living Kidney Donors.
C. Dorr,^1,2,3 A. Hart,^1,2,3 D. Schladt,¹ A. Muthusamy,¹ R. Mannon,⁴ W. Oetting,² A. Matas,² P. Jacobson,² A. Israni.^1,2,3
¹Minneapolis Medical Research Foundation, Minneapolis; ²University of Minnesota, Minneapolis; ³Hennepin County Medical Center, Minneapolis; ⁴University of Alabama, Birmingham.
Background:Apolipoprotein L1 (APOL1) alleles G1 and G2 in deceased donors are associated with poor kidney allograft survival. However, the effect of these alleles in living…